| Autor: |
Campa MJ; Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA., McNutt RW, Hill JA, Patz EF, Chang KJ |
| Jazyk: |
angličtina |
| Zdroj: |
European journal of pharmacology [Eur J Pharmacol] 1996 Aug 29; Vol. 310 (2-3), pp. 263-7. |
| DOI: |
10.1016/0014-2999(96)00483-9 |
| Abstrakt: |
A tritiated form of the non-peptide delta-opioid receptor agonist (+)-BW373U86 ((+)-4-((alpha-R)-alpha-((2S,5R)-4-allyl-2, 5-dimethyl-l-piperazinyl)-3-hydroxybenzyl)-N,N-diethylbenzamide) was synthesized and its binding characteristics studied. [3H](+)-BW373U86 bound with subnanomolar affinity to rat brain membranes and was displaced most effectively by ligands selective for delta-opioid receptors. Naltrindole, naltriben, and 7-benzylidenenaltrexone exhibited apparent inhibition constants of 0.06, 1.54, and 4.49 nM, respectively, while mu- or kappa-selective ligands showed little affinity for this site. [3H](+)-BW373U86 binding was sensitive to the presence of guanine nucleotides; GDP caused a 3-fold decrease and 5'-guanylyl-imidodiphosphate (Gpp[NH]p) caused a 25% increase in binding affinity. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect